Boston, MA 10/24/2013 (wallstreetpr) – Being the diversified company UnitedHealth Group Inc. (NYSE:UNH), OptumHealth, OptumInsight and OptumRx are all subsidiaries of the company. In the Minneapolis-St. Paul east metro area, HealthEast Care System is one of the biggest healthcare firms and has successfully implemented Optum’s clinical analytics process in order to improve accountable-case strategies and population health management. The latest addition of Mercy Health Care among the client list of OptumRx has brought Optum into spotlight and has increased the number of investors for UnitedHealth.
The details of the implementation
Humedica Analytics is the platform, created by Optum and used by the two health care giants. The analytics software has to be fed data regarding clinical details or administrative details before it can be used for identifying potential loopholes in the administration or in patient care. It helps HealthEast Care System to discover the probability of a patient being re-hospitalized or developing severe form of the disease just by running analytics. This helps the health care firms to identify top priority patients and issues to be dealt with.
Dr. Brian Patty, vice president and chief medical informatics officer, HealthEast was satisfied with the software’s performance since it was able to aptly identify the gaps in the system and the potential risks. Marc Gunter, M.D., clinical vice president at Mercy said that not only was the software efficient but also scalable for large systems. Mary Lantin, vice president of client services at Humedica, was a happy seller as she felt that the potential of the analytics software was optimally tapped by both health care systems. With this as a start she said that the company was focused on expanding its customer base.
Market performance
On Tuesday, October 22, the share price of the company touched an intra-day high of $69.20 but otherwise remained stable. Immediately the next day investors saw a decrease in the price to an intra-day low of $67.77. The company shares are quite unstable and are at a month long low value. So now is a good time for the investors to buy some.
